Search by Drug Name or NDC
NDC 16571-0812-05 Trientine Hydrochloride 500 mg/1 Details
Trientine Hydrochloride 500 mg/1
Trientine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is TRIENTINE HYDROCHLORIDE.
Product Information
NDC | 16571-0812 |
---|---|
Product ID | 16571-812_642b3258-7418-4209-bb88-2ca277a4fb2b |
Associated GPIs | |
GCN Sequence Number | 085351 |
GCN Sequence Number Description | trientine HCl CAPSULE 500 MG ORAL |
HIC3 | C8A |
HIC3 Description | METALLIC POISON,AGENTS TO TREAT |
GCN | 54809 |
HICL Sequence Number | 001109 |
HICL Sequence Number Description | TRIENTINE HCL |
Brand/Generic | Generic |
Proprietary Name | Trientine Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Trientine Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 500 |
Active Ingredient Units | mg/1 |
Substance Name | TRIENTINE HYDROCHLORIDE |
Labeler Name | Rising Pharma Holdings, Inc. |
Pharmaceutical Class | Copper Chelating Activity [MoA], Copper Chelator [EPC], Metal Chelating Activity [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA212238 |
Listing Certified Through | 2024-12-31 |
Package
NDC 16571-0812-05 (16571081205)
NDC Package Code | 16571-812-05 |
---|---|
Billing NDC | 16571081205 |
Package | 50 CAPSULE in 1 BOTTLE (16571-812-05) |
Marketing Start Date | 2023-09-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |